Ongoing revenue growth from our ex-U.S. Crinone franchise and contract pharmaceutical services business provides, coupled with our strengthened balance sheet, enables targeted investments in product development.
We are building our proprietary pipeline using our novel drug delivery technologies to develop therapeutics that address unmet and underserved medical needs in women’s health. Current candidates leverage our multi-segment intravaginal ring delivery platform and the 505(b)(2) regulatory pathway.
We are looking expand our progressive and innovative organisation. If you are driven to tackle challenges and enjoy working in a collaborative environment as a valued team member, we would like to hear from you.
Due to our rapid growth, we are seeking talented scientists to complement our current team in several new, full-time, permanent positions:
Juniper Pharmaceuticals is an Equal Opportunity Employer.
Crinone® is a registered trademark of Merck KGaA, Darmstadt, Germany, outside the U.S. and of Allergan, Inc. in the U.S.